Pemetrexed tromethamine

Pemetrexed ditromethamine dihydrate is a chemotherapy drug used mainly for the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). It is often administered in combination with cisplatin for initial treatment in these cancers and can be used as monotherapy for maintenance treatment or after prior chemotherapy in non-squamous NSCLC cases. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pemetrexed ditromethamine dihydrate. Its PubChem CID is 135565678.

CAS No 1851348-04-3
Molecular Formula C28H47N7O14
Molecular Weight 705.7 g/mol
Synonyms 2-amino-2-(hydroxymethyl)propane-1,3-diol;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;dihydrate

Frequently Asked Questions